One Drop App With an Activity Tracker for Adults With Type 1 Diabetes: Randomized Controlled Trial.

ABSTRACT:

Background

In 2017, mobile app support for managing diabetes was available to 64% of the global population of adults with diabetes. One Drop's digital therapeutics solution includes an evidence-based mobile app with global reach, a Bluetooth-connected glucometer, and in-app coaching from Certified Diabetes Educators. Among people with type 1 diabetes and an estimated hemoglobin A_1c level≥7.5%, using One Drop for 3 months has been associated with an improved estimated hemoglobin A_1c level of 22.2 mg/dL (-0.80%). However, the added value of integrated activity trackers is unknown.

Objective

We conducted a pragmatic, remotely administered randomized controlled trial to evaluate One Drop with a new-to-market activity tracker against One Drop only on the 3-m

SUBMITTER: Osborn CY 

PROVIDER: S-EPMC7530691 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature